Stroke and bleeding risk factors
Patients selected to rhythm control strategy had lower mean
CHA2DS2-VASc score (2.7±1.7 vs. 3.8±1.8)
and mean HAS-BLED score (1.6±1.1 vs. 2.2±1.2) than those with rate
control, (both p<0.001). The rhythm control group includes
significantly lower proportion of patients with
CHA2DS2-VASc score ≥2 and with HAS-BLED
score ≥3 (both p < 0.001) than those with rate control. They
have also significantly higher proportion of ‘low risk’ patients with
CHA2DS2-VASc score of 0 in males or of 1
in females (p <0.001) than patients with rate control (Table
2).